NDC 68040-702

Alcortin

1% Iodoquinol - 2% Hydrocortisone

Alcortin is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Primus Pharmaceuticals. The primary component is Hydrocortisone; Iodoquinol.

Product ID68040-702_4acf85e5-f2d5-40b0-8562-2427a2ab56be
NDC68040-702
Product TypeHuman Prescription Drug
Proprietary NameAlcortin
Generic Name1% Iodoquinol - 2% Hydrocortisone
Dosage FormGel
Route of AdministrationTOPICAL
Marketing Start Date2003-07-25
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NamePrimus Pharmaceuticals
Substance NameHYDROCORTISONE; IODOQUINOL
Active Ingredient Strength2 g/100g; g/100g
Pharm ClassesCorticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 68040-702-08

64 CARTON in 1 BOX (68040-702-08) > 10 PACKET in 1 CARTON > 2 g in 1 PACKET (68040-702-02)
Marketing Start Date2003-07-25
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68040-702-13 [68040070213]

Alcortin GEL
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2003-07-25
Inactivation Date2019-10-21

NDC 68040-702-08 [68040070208]

Alcortin GEL
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2003-07-25
Inactivation Date2019-10-21

NDC 68040-702-02 [68040070202]

Alcortin GEL
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2003-07-25

Drug Details

Active Ingredients

IngredientStrength
HYDROCORTISONE2 g/100g

OpenFDA Data

SPL SET ID:995ae132-8e37-4fda-b353-ce79ab9d0bf4
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1191414
  • 544118
  • Pharmacological Class

    • Corticosteroid [EPC]
    • Corticosteroid Hormone Receptor Agonists [MoA]

    Trademark Results [Alcortin]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ALCORTIN
    ALCORTIN
    78308199 3012076 Live/Registered
    NOVUM PHARMA, LLC
    2003-10-01

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.